NeoGenomics, Inc. (NEO)
NASDAQ: NEO · IEX Real-Time Price · USD
14.51
-0.23 (-1.56%)
At close: Jul 19, 2024, 4:00 PM
14.44
-0.07 (-0.48%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
NeoGenomics Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for NeoGenomics stock have an average target of 19.78, with a low estimate of 17 and a high estimate of 26. The average target predicts an increase of 36.32% from the current stock price of 14.51.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 2, 2024.
Analyst Ratings
The average analyst rating for NeoGenomics stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 6 | 6 | 6 |
| Buy | 3 | 3 | 3 | 2 | 2 | 2 |
| Hold | 3 | 3 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 9 | 10 | 10 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Maintains $23 → $21 | Strong Buy | Maintains | $23 → $21 | +44.73% | May 2, 2024 |
| Benchmark | Benchmark | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +24.05% | May 1, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $21 → $20 | Strong Buy | Maintains | $21 → $20 | +37.84% | May 1, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $26 | Strong Buy | Initiates | $26 | +79.19% | May 1, 2024 |
| Needham | Needham | Strong Buy Maintains $24 → $19 | Strong Buy | Maintains | $24 → $19 | +30.94% | Apr 30, 2024 |
Financial Forecast
Revenue This Year
662.22M
from 591.64M
Increased by 11.93%
Revenue Next Year
726.46M
from 662.22M
Increased by 9.70%
EPS This Year
0.02
from -0.70
EPS Next Year
0.17
from 0.02
Increased by 661.75%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 692.0M | 764.0M | 844.6M |
| Avg | 662.2M | 726.5M | 800.6M |
| Low | 638.0M | 695.8M | 763.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 17.0% | 15.4% | 16.3% |
| Avg | 11.9% | 9.7% | 10.2% |
| Low | 7.8% | 5.1% | 5.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.06 | 0.32 | 0.46 |
| Avg | 0.02 | 0.17 | 0.35 |
| Low | -0.01 | 0.07 | 0.19 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | 1,347.9% | 178.8% |
| Avg | - | 661.7% | 109.8% |
| Low | - | 215.3% | 12.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.